日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells

TMIGD2 是人类急性髓系白血病干细胞的调控因子和治疗靶点

Hao Wang, R Alejandro Sica, Gurbakhash Kaur, Phillip M Galbo Jr, Zhixin Jing, Christopher D Nishimura, Xiaoxin Ren, Ankit Tanwar, Bijan Etemad-Gilbertson, Britta Will, Deyou Zheng, David Fooksman, Xingxing Zang2

TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors

TOP CAR 以 TMIGD2 作为 CAR 细胞中安全有效的共刺激结构域,用于治疗人类实体肿瘤

Christopher D Nishimura, Devin Corrigan, Xiang Yu Zheng, Phillip M Galbo Jr, Shan Wang, Yao Liu, Yao Wei, Linna Suo, Wei Cui, Nadia Mercado, Deyou Zheng, Cheng Cheng Zhang, Xingxing Zang

A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression

SOX9-B7x轴保护去分化肿瘤细胞免受免疫监视,从而驱动乳腺癌进展。

Yu Liu,Peter John,Kenta Nishitani,Jihong Cui,Christopher D Nishimura,John R Christin,Nicole Couturier,Xiaoxin Ren,Yao Wei,Marc C Pulanco,Phillip M Galbo Jr,Xusheng Zhang,Wenyan Fu,Wei Cui,Boris A Bartholdy,Deyou Zheng,Gregoire Lauvau,Susan A Fineberg,Maja H Oktay,Xingxing Zang,Wenjun Guo